These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24791590)

  • 1. A novel brain targeted 5-fU derivative with potential antitumor efficiency and decreased acute toxicity: synthesis, in vitro and in vivo evaluation.
    Chen H; Wu W; Li Y; Gong T; Sun X; Zhang Z
    Pharmazie; 2014 Apr; 69(4):271-6. PubMed ID: 24791590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites.
    Wang GP; Guan YS; Jin XR; Jiang SS; Lu ZJ; Wu Y; Li Y; Li M; Luo F
    J Gastroenterol Hepatol; 2010 May; 25(5):985-90. PubMed ID: 20546454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytotoxicity, in vivo biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates.
    Yuan F; Qin X; Zhou D; Xiang QY; Wang MT; Zhang ZR; Huang Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):770-6. PubMed ID: 18656539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro release study, in vivo evaluation of biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates].
    Yuan F; Zhang ZR; Yang YX; Huang Y
    Yao Xue Xue Bao; 2008 Nov; 43(11):1152-6. PubMed ID: 19239037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
    Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
    Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice.
    Hao X; Cheng G; Zou M; Sun J; Cui F
    Pharmazie; 2004 Sep; 59(9):709-12. PubMed ID: 15497754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of stealth liposome formulation of 2'-deoxyinosine as 5-fluorouracil modulator: in vitro and in vivo study.
    Fanciullino R; Giacometti S; Aubert C; Fina F; Martin PM; Piccerelle P; Ciccolini J
    Pharm Res; 2005 Dec; 22(12):2051-7. PubMed ID: 16222443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
    Puri R; Jain S
    Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of a novel 5-fluorouracil (5-FU) derivative to 5-FU in rats.
    Takada K; Yoshikawa H; Muranishi S
    Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):99-108. PubMed ID: 6867473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro.
    Qiao J; Gu C; Shang W; Du J; Yin W; Zhu M; Wang W; Han M; Lu W
    Food Chem Toxicol; 2011 Jun; 49(6):1410-5. PubMed ID: 21440026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthesis and antitumor activity of new heterocyclic 5-fluorouracil derivatives].
    Mao M; Chen Y; Tian X
    Yao Xue Xue Bao; 1998 May; 33(5):389-91. PubMed ID: 12017008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and distribution of 5-Fu magnetic albumin deuto-microsphere in normal and tumor-bearing mice].
    Xu R; Shi SJ; Zhou SC; Zheng JW; Chen H; Zou SQ; Zeng FD
    Yao Xue Xue Bao; 2007 Jan; 42(1):66-70. PubMed ID: 17520810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
    Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of 5-fluorouracil (5-FU) in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Kosovec JE; Egorin MJ; Gjurich S; Beumer JH
    Rapid Commun Mass Spectrom; 2008; 22(2):224-30. PubMed ID: 18085512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic characteristics and antitumor activity of BOF-A2, a new 5-fluorouracil derivative].
    Shirasaka T; Fukushima M; Shimamoto Y; Kimura Y; Ohshimo H; Imaoka T; Kimura A; Utsunomiya T; Fujii S
    Gan To Kagaku Ryoho; 1990 May; 17(5):1051-8. PubMed ID: 2334171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and passive target of 5-fluorouracil solid lipid nanoparticles.
    Du B; Yan Y; Li Y; Wang S; Zhang Z
    Pharm Dev Technol; 2010; 15(4):346-53. PubMed ID: 19769532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate) to rats.
    Yoshisue K; Masuda H; Matsushima E; Ikeda K; Nagayama S; Kawaguchi Y
    Drug Metab Dispos; 2000 Oct; 28(10):1162-7. PubMed ID: 10997934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity and antitumour activity of 5-fluorouracil-loaded polyhydroxybutyrate and cellulose acetate phthalate blend microspheres.
    Chaturvedi K; Tripathi SK; Kulkarni AR; Aminabhavi TM
    J Microencapsul; 2013; 30(4):356-68. PubMed ID: 23078151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.